These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32151678)

  • 1. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.
    He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B
    Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model.
    Zhu Y; Teng T; Wang H; Guo H; Du L; Yang B; Yin X; Sun Y
    Food Funct; 2018 Jan; 9(1):389-396. PubMed ID: 29215110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obacunone Retards Renal Cyst Development in Autosomal Dominant Polycystic Kidney Disease by Activating NRF2.
    Qiu Z; He J; Shao G; Hu J; Li X; Zhou H; Li M; Yang B
    Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginkgolide B inhibits renal cyst development in in vitro and in vivo cyst models.
    Zhou H; Gao J; Zhou L; Li X; Li W; Li X; Xia Y; Yang B
    Am J Physiol Renal Physiol; 2012 May; 302(10):F1234-42. PubMed ID: 22338085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease.
    Li LX; Zhang L; Agborbesong E; Zhang X; Zhou JX; Li X
    Am J Physiol Renal Physiol; 2022 Aug; 323(2):F227-F242. PubMed ID: 35759739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease.
    Wang W; Geng X; Lei L; Jia Y; Li Y; Zhou H; Verkman AS; Yang B
    FASEB J; 2019 May; 33(5):6185-6196. PubMed ID: 30768374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inositol 1,4,5-triphosphate receptor 3 promotes renal cyst development in autosomal dominant polycystic kidney disease].
    Qiu ZW; Liu M; Zhou H; Yang BX
    Sheng Li Xue Bao; 2023 Jun; 75(3):328-338. PubMed ID: 37340642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganoderic acid A is the effective ingredient of Ganoderma triterpenes in retarding renal cyst development in polycystic kidney disease.
    Meng J; Sai-Zhen Wang ; He JZ; Zhu S; Huang BY; Wang SY; Li M; Zhou H; Lin SQ; Yang BX
    Acta Pharmacol Sin; 2020 Jun; 41(6):782-790. PubMed ID: 31911637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone inhibits transforming growth factor-β1 mediated fibrogenesis in ADPKD cyst-lining epithelial cells.
    Liu Y; Dai B; Xu C; Fu L; Hua Z; Mei C
    PLoS One; 2011; 6(12):e28915. PubMed ID: 22174924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis.
    Buchholz B; Klanke B; Schley G; Bollag G; Tsai J; Kroening S; Yoshihara D; Wallace DP; Kraenzlin B; Gretz N; Hirth P; Eckardt KU; Bernhardt WM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3458-65. PubMed ID: 21804086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Indanone retards cyst development in ADPKD mouse model by stabilizing tubulin and down-regulating anterograde transport of cilia.
    Li XW; Ran JH; Zhou H; He JZ; Qiu ZW; Wang SY; Wu MN; Zhu S; An YP; Ma A; Li M; Quan YZ; Li NN; Ren CQ; Yang BX
    Acta Pharmacol Sin; 2023 Feb; 44(2):406-420. PubMed ID: 35906293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganoderma triterpenes retard renal cyst development by downregulating Ras/MAPK signaling and promoting cell differentiation.
    Su L; Liu L; Jia Y; Lei L; Liu J; Zhu S; Zhou H; Chen R; Lu HAJ; Yang B
    Kidney Int; 2017 Dec; 92(6):1404-1418. PubMed ID: 28709639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector.
    Yanda MK; Liu Q; Cebotaru L
    J Biol Chem; 2018 Jul; 293(29):11513-11526. PubMed ID: 29875161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease.
    Veeraphan P; Chavasiri W; Muanprasat C; Chatsudthipong V; Yuajit C
    Clin Exp Nephrol; 2021 Sep; 25(9):944-952. PubMed ID: 34057612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease.
    Dwivedi N; Jamadar A; Mathew S; Fields TA; Rao R
    Kidney Int; 2023 Jan; 103(1):144-155. PubMed ID: 36273656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.
    Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP
    J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
    Sundar SV; Zhou JX; Magenheimer BS; Reif GA; Wallace DP; Georg GI; Jakkaraj SR; Tash JS; Yu ASL; Li X; Calvet JP
    Am J Physiol Renal Physiol; 2022 Oct; 323(4):F492-F506. PubMed ID: 35979967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro.
    Ye M; Grant M; Sharma M; Elzinga L; Swan S; Torres VE; Grantham JJ
    J Am Soc Nephrol; 1992 Oct; 3(4):984-94. PubMed ID: 1333294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
    Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease.
    Jamadar A; Suma SM; Mathew S; Fields TA; Wallace DP; Calvet JP; Rao R
    Cell Death Dis; 2021 Oct; 12(10):947. PubMed ID: 34650051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.